Toward a Future Where Diabetes No Longer Limits Mesh Surgery

The authors aim to address how diabetes impacts the outcomes of synthetic mesh implantation in urogynecologic pelvic reconstructive surgery, highlighting the need for improved perioperative glucose management tailored to individual patients. They emphasize the inadequacy of current predictive markers for mesh-related complications and advocate for a precision medicine approach that incorporates patient-specific factors, mechanistic studies, and biomarker discovery to enhance surgical outcomes.